McDonald’s Projected Revenue Increase and Merck’s Latest on CNBC’s ‘Final Trades’
MacDonald’s Projected Revenue Increase and Merck’s Latest on CNBC’s ‘Final Trades’
CNBC’s “Halftime Report Final Trades” featured Joseph Terranova of Virtus Investment Partners, naming Merck & Co., Inc. as his final trade. The FDA issued a Complete Response Letter (CRL) regarding Merck’s New Drug Application (NDA) for gefapixant under development for the treatment of refractory chronic …